Goldman Sachs Group Inc. lifted its position in Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) by 147.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,824 shares of the medical equipment provider’s stock after purchasing an additional 35,086 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Corindus Vascular Robotics were worth $109,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in Corindus Vascular Robotics by 57.6% during the second quarter. Vanguard Group Inc. now owns 3,279,185 shares of the medical equipment provider’s stock worth $6,100,000 after acquiring an additional 1,198,384 shares in the last quarter. Northern Trust Corp raised its stake in Corindus Vascular Robotics by 42.4% during the second quarter. Northern Trust Corp now owns 959,920 shares of the medical equipment provider’s stock worth $1,786,000 after acquiring an additional 285,811 shares in the last quarter. New York State Common Retirement Fund raised its stake in Corindus Vascular Robotics by 334.6% during the second quarter. New York State Common Retirement Fund now owns 89,100 shares of the medical equipment provider’s stock worth $166,000 after acquiring an additional 68,599 shares in the last quarter. TIAA CREF Investment Management LLC raised its stake in Corindus Vascular Robotics by 74.5% during the second quarter. TIAA CREF Investment Management LLC now owns 225,233 shares of the medical equipment provider’s stock worth $419,000 after acquiring an additional 96,156 shares in the last quarter. Finally, Teachers Advisors LLC raised its stake in Corindus Vascular Robotics by 184.7% during the second quarter. Teachers Advisors LLC now owns 167,633 shares of the medical equipment provider’s stock worth $312,000 after acquiring an additional 108,745 shares in the last quarter.

Several analysts have recently commented on the company. Zacks Investment Research upgraded Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.00 target price on the stock in a report on Monday, November 13th. BidaskClub cut Corindus Vascular Robotics from a “sell” rating to a “strong sell” rating in a report on Wednesday, October 11th. Finally, ValuEngine cut Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. Two investment analysts have rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $2.33.

Shares of Corindus Vascular Robotics Inc (NYSEAMERICAN CVRS) opened at $1.15 on Friday. Corindus Vascular Robotics Inc has a 1-year low of $0.40 and a 1-year high of $2.25.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its earnings results on Tuesday, November 7th. The medical equipment provider reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.01. The company had revenue of $2.43 million for the quarter, compared to analysts’ expectations of $3.60 million. Corindus Vascular Robotics had a negative return on equity of 94.27% and a negative net margin of 372.63%.

TRADEMARK VIOLATION WARNING: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.watchlistnews.com/goldman-sachs-group-inc-purchases-35086-shares-of-corindus-vascular-robotics-inc-cvrs/1723971.html.

Corindus Vascular Robotics Company Profile

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Want to see what other hedge funds are holding CVRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS).

Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.